Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.
about
Role of exosomes/microvesicles in the nervous system and use in emerging therapiesCOX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.What's the place of immunotherapy in malignant mesothelioma treatments?Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activity.Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma.Investigational approaches for mesothelioma.New roads open up for implementing immunotherapy in mesothelioma.The application of exosomes as a nanoscale cancer vaccine.Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials.Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.Update in lung cancer 2005.mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor ImmunityTumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma.Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.Malignant pleural mesothelioma: from the bench to the bedside.Dendritic cell-based immunotherapy in mesothelioma.Advances in malignant peritoneal mesothelioma.Immunotherapy prospects in the treatment of lung cancer and mesothelioma.A catalogue of treatment and technologies for malignant pleural mesothelioma.Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy.Immunotherapy advances for mesothelioma treatment.Soluble Mesothelin–related Peptides in the Diagnosis of Malignant Pleural MesotheliomaMalignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives
P2860
Q21129255-3C31425D-9CF9-4AFF-AC75-3C0A335F0482Q33678308-C4568D50-3068-4C6C-A88D-112CE0A2AD12Q33781142-9E568197-8E19-4E80-B0D6-7C2B039C92DDQ33871059-46AAFEE0-92C6-4258-B1A3-035AF43B4658Q34122791-D213AAAC-FEF2-4167-871E-30014EE65B9EQ34293068-C3043BDD-5F60-43A7-9375-39C3EFA9B3A9Q34331993-2078177F-AD8A-4E8F-803E-06D1BC324039Q34343272-D6373DF3-1612-4348-9D21-BEB9CC2FEEA2Q34788477-EEEE7866-312A-473E-B5CC-554E5177EF22Q35042668-7265878A-6725-4FCE-B939-3DD415EB398CQ35440540-CF0E7A64-DC98-46AD-9BB7-1DD8B58D7239Q35711576-0777ECC5-0EDF-47F6-90AE-22387139B0C7Q36429911-E89905DE-0324-47A2-A532-88E408AD90B0Q36757007-939AFCA9-C03E-4126-B289-6DFB441794B3Q37295688-0B6529D7-AC9A-4B06-A83C-3B2EC7946BE2Q37635491-3BA56C12-DF43-4149-B245-80622A5158D9Q38019747-A43470B5-DD9C-4E66-A2DA-01368196EBE1Q38059514-DB80AB41-337D-48FF-B36C-F85D0A566584Q38261500-908B68CC-81FB-4516-A81B-C7AAFD9DFACCQ38390104-0949F408-DE5C-4B97-8B90-F63D26762107Q38760623-E3D88EFD-A08F-4E90-887F-76709895A3AEQ39415827-7A3C5C30-2EDA-4D49-87AD-BCAF2E24A905Q40365927-FADB1422-803D-4462-93CC-6EC33E62D348Q42910288-3B0A4C95-3681-4C27-8A27-679A8EB52881Q49177347-EBE87303-AF83-4601-AB47-FADA125E0796Q51823843-29F7040E-58A2-41D7-A870-046988CA5D0AQ57554489-0CDA04D4-108E-4A26-8BB8-5851C3CD0D2AQ58541846-6BFD6A06-9EF4-4A54-A247-4AC90C295A07
P2860
Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.
@en
type
label
Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.
@en
prefLabel
Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.
@en
P2093
P2860
P1476
Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.
@en
P2093
Annabrita Hemmes
Bart N Lambrecht
Henk C Hoogsteden
Joachim G Aerts
Joost P J J Hegmans
P2860
P304
P356
10.1164/RCCM.200501-057OC
P407
P577
2005-03-11T00:00:00Z